Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson's Disease
Liang Huang(Georgetown University), Howard J. Federoff(Georgetown University Medical Center)
Cited by 4
Related Papers
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
|Frontiers in Aging Neuroscience|2017|338
The Endoplasmic Reticulum Stress Response Factor CHOP-10 Protects against Hypoxia-induced Neuronal Death
|Journal of Biological Chemistry|2010|56